Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

John A Thompson

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Neurosurgery
Phone303/724-8581

    Collapse Research 
    Collapse research activities and funding
    R01CA041248     (THOMPSON, JOHN A)Mar 1, 1986 - Jul 31, 2008
    NIH/NCI
    Bioactivation of Dietary Phenols by Hemoproteins
    Role: Principal Investigator

    S10RR004996     (THOMPSON, JOHN A)Sep 30, 1988 - Sep 29, 1989
    NIH/NCRR
    LIQUID CHROMATOGRAPH-MASS SPECTROMETER
    Role: Principal Investigator

    R01HL048491     (THOMPSON, JOHN ANTHONY)Apr 1, 1992 - Jan 31, 1996
    NIH/NHLBI
    PATHOLOGICAL ANGIOGENESIS--REGULATION BY TAT AND HBGF-1
    Role: Principal Investigator

    R01HL045990     (THOMPSON, JOHN ANTHONY)Feb 1, 1993 - Mar 31, 2008
    NIH/NHLBI
    Molecular Mechanisms of Angiogenesis
    Role: Principal Investigator

    R01ES006216     (THOMPSON, JOHN A)May 1, 1994 - Apr 30, 1997
    NIH/NIEHS
    FORMATION AND REACTIVITY OF TOXIC QUINONE METHIDES
    Role: Principal Investigator

    R01DK051629     (THOMPSON, JOHN ANTHONY)Aug 22, 1997 - May 31, 2002
    NIH/NIDDK
    PRECLINICAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION
    Role: Principal Investigator

    S10RR012974     (THOMPSON, JOHN A)May 15, 1998 - May 14, 1999
    NIH/NCRR
    ACQUISTION OF AN ELECTROSPRAY TANDEM MASS SPECTROMETER
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stratford JM, Thompson JA, Finger TE. Immunocytochemical organization and sour taste activation in the rostral nucleus of the solitary tract of mice. J Comp Neurol. 2017 Feb 01; 525(2):271-290. PMID: 27292295.
      View in: PubMed
    2. Dondzillo A, Thompson JA, Klug A. Recurrent Inhibition to the Medial Nucleus of the Trapezoid Body in the Mongolian Gerbil (Meriones Unguiculatus). PLoS One. 2016; 11(8):e0160241. PMID: 27489949; PMCID: PMC4973988.
    3. Stratford JM, Thompson JA. Beta-galactosidase staining in the nucleus of the solitary tract of Fos-Tau-LacZ mice is unaffected by monosodium glutamate taste stimulation. PLoS One. 2014; 9(9):e107238. PMID: 25192442; PMCID: PMC4156431.
    4. Thompson JA, Salcedo E, Restrepo D, Finger TE. Second-order input to the medial amygdala from olfactory sensory neurons expressing the transduction channel TRPM5. J Comp Neurol. 2012 Jun 01; 520(8):1819-30. PMID: 22120520; PMCID: PMC3716388.
    5. Shrestha SP, Thompson JA, Wempe MF, Gu M, Agarwal R, Agarwal C. Glucuronidation and methylation of procyanidin dimers b2 and 3,3?-di-o-galloyl-b2 and corresponding monomers epicatechin and 3-o-galloyl-epicatechin in mouse liver. Pharm Res. 2012 Mar; 29(3):856-65. PMID: 22068277; PMCID: PMC3288310.
    6. Shearn CT, Fritz KS, Thompson JA. Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene. Chem Biol Interact. 2011 Jul 15; 192(3):278-86. PMID: 21536018.
      View in: PubMed
    7. Chou SC, Kaur M, Thompson JA, Agarwal R, Agarwal C. Influence of gallate esterification on the activity of procyanidin B2 in androgen-dependent human prostate carcinoma LNCaP cells. Pharm Res. 2010 Apr; 27(4):619-27. PMID: 20162340; PMCID: PMC4208699.
    8. Shearn CT, Fritz KS, Meier BW, Kirichenko OV, Thompson JA. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Chem Res Toxicol. 2008 Aug; 21(8):1631-41. PMID: 18597497.
      View in: PubMed
    9. Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Invest New Drugs. 2006 Jan; 24(1):89-94. PMID: 16379038.
      View in: PubMed
    Thompson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)